Yuanfeng Du
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuanfeng Du has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Yang Cao
Department of Neurosurgery, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University
2 shared publicationsChenglong Sun
The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China
1 shared publicationDing Wang
Department of Neurosurgery, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University
1 shared publicationHaiyang Wang
Department of Neurosurgery, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University
1 shared publicationJiadong Wang
The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University
1 shared publication- Jie Zhang
Department of Neurosurgery, Hangzhou First People Hospital, Hangzhou, China
1 shared publication
Latest Publications
- Open Access
- 20 April 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2654257
Efficacy analysis of combined nerve combing and decompression for occipital neuralgia based on the classification of neurovascular relationships
This study set occipital pain improvement as the primary endpoint, and overall headache relief, migraine index, medication use and complication rate as secondary endpoints, to evaluate the efficacy and safety of neural combing plus decompression guided by four neurovascular relationship subtypes for drug-resistant occipital neuralgia (ON). We retrospectively reviewed 53 patients with drug-resistant ON who underwent unilateral or bilateral greater occipital nerve (GON) combing and decompression. All had ineffective drug treatment for ≥1 year and follow-up ≥12 months. Efficacy was evaluated by comparing monthly pain days, Visual Analog Scale (VAS), medication use and migraine index pre- and postoperatively. Complications were recorded. Postoperatively, 88.7% (47/53) of patients achieved ≥50% ON improvement, and 67.9% (36/53) had complete pain remission. Monthly chronic pain days fell by 72.6%, attack days by 85.0%. Baseline VAS decreased from 2.6 to 1.0, peak attack VAS from 6.4 to 0.8. Medication use dropped by 70%, with significant reductions in NSAIDs, triptans and opioids (P < 0.01). Only one minor complication occurred, with no severe adverse events. The combined GON combing and decompression technique guided by the four subtypes of neurovascular relationships enables the precise release of nerve compression points while preserving neural structures. It significantly improves pain symptoms and quality of life in patients with drug-resistant ON, offering minimal trauma and fewer complications. Hence, this technique is a safe and valuable minimally invasive therapeutic option for the invasive treatment of drug-resistant ON, which warrants further prospective comparative studies and wider clinical application.
- 20 April 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2654257
Open AccessEfficacy analysis of combined nerve combing and decompression for occipital neuralgia based on the classification of neurovascular relationships
This study set occipital pain improvement as the primary endpoint, and overall headache relief, migraine index, medication use and complication rate as secondary endpoints, to evaluate the efficacy and safety of neural combing plus decompression guided by four neurovascular relationship subtypes for drug-resistant occipital neuralgia (ON). We retrospectively reviewed 53 patients with drug-resistant ON who underwent unilateral or bilateral greater occipital nerve (GON) combing and decompression. All had ineffective drug treatment for ≥1 year and follow-up ≥12 months. Efficacy was evaluated by comparing monthly pain days, Visual Analog Scale (VAS), medication use and migraine index pre- and postoperatively. Complications were recorded. Postoperatively, 88.7% (47/53) of patients achieved ≥50% ON improvement, and 67.9% (36/53) had complete pain remission. Monthly chronic pain days fell by 72.6%, attack days by 85.0%. Baseline VAS decreased from 2.6 to 1.0, peak attack VAS from 6.4 to 0.8. Medication use dropped by 70%, with significant reductions in NSAIDs, triptans and opioids (P < 0.01). Only one minor complication occurred, with no severe adverse events. The combined GON combing and decompression technique guided by the four subtypes of neurovascular relationships enables the precise release of nerve compression points while preserving neural structures. It significantly improves pain symptoms and quality of life in patients with drug-resistant ON, offering minimal trauma and fewer complications. Hence, this technique is a safe and valuable minimally invasive therapeutic option for the invasive treatment of drug-resistant ON, which warrants further prospective comparative studies and wider clinical application.
- Open Access
- 23 February 2022
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 826653
Treatment of Third Branch Trigeminal Neuralgia With a Balloon Inflated in the Foramen Ovale
Objective: To investigate the efficacy of modified percutaneous balloon compression for simple third branch pain and its postoperative complications.Methods: Clinical data and surgical records of 132 patients with third branch pain treated with percutaneous balloon compression from March 2015 to May 2019 were retrospectively analyzed, of which 81 cases were in the modified group and 51 cases were in the classic group. The modified technique was to compress again at the foramen ovale to enhance the compression in V3 after compression of the Gasserian ganglion.Results: In the modified group, the overall therapeutic efficiency was 96.3%, with 77 patients (95.1%) having immediate postoperative pain relief and one patient (1.2%) having occasional pain without the need for medication. In the classic group, immediate postoperative pain relief was seen in 43 cases (84.3%), and two patients (3.9%) had occasional pain with no need for medication. The rate of complete pain relief was significantly higher in the modified group than in the classic group (P < 0.05). Postoperative follow-up ranged from 14 to 48 months. The pain-free rates were 77.8 and 54.9% in the modified and classic groups, respectively. The incidence of facial numbness in the region of the first branch was significantly lower than in the classic group (P < 0.001).Conclusion: The modified procedure has significant advantages over the classic procedure in improving surgical efficacy, reducing postoperative recurrence rate, and decreasing postoperative numbness in the region, and can be used to treat simple trigeminal neuralgia in the third branch.
- 23 February 2022
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 826653
Open AccessTreatment of Third Branch Trigeminal Neuralgia With a Balloon Inflated in the Foramen Ovale
Objective: To investigate the efficacy of modified percutaneous balloon compression for simple third branch pain and its postoperative complications.Methods: Clinical data and surgical records of 132 patients with third branch pain treated with percutaneous balloon compression from March 2015 to May 2019 were retrospectively analyzed, of which 81 cases were in the modified group and 51 cases were in the classic group. The modified technique was to compress again at the foramen ovale to enhance the compression in V3 after compression of the Gasserian ganglion.Results: In the modified group, the overall therapeutic efficiency was 96.3%, with 77 patients (95.1%) having immediate postoperative pain relief and one patient (1.2%) having occasional pain without the need for medication. In the classic group, immediate postoperative pain relief was seen in 43 cases (84.3%), and two patients (3.9%) had occasional pain with no need for medication. The rate of complete pain relief was significantly higher in the modified group than in the classic group (P < 0.05). Postoperative follow-up ranged from 14 to 48 months. The pain-free rates were 77.8 and 54.9% in the modified and classic groups, respectively. The incidence of facial numbness in the region of the first branch was significantly lower than in the classic group (P < 0.001).Conclusion: The modified procedure has significant advantages over the classic procedure in improving surgical efficacy, reducing postoperative recurrence rate, and decreasing postoperative numbness in the region, and can be used to treat simple trigeminal neuralgia in the third branch.